Compounds > dichlororibofuranosylbenzimidazole
Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Cancer of Pituitary

dichlororibofuranosylbenzimidazole has been researched along with Cancer of Pituitary in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, J1
Tashjian, AH1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Cancer of Pituitary

ArticleYear
Regulation of endogenous thyrotropin-releasing hormone receptor messenger RNA in GH4C1 cells: roles of protein and RNA synthesis.
    Molecular endocrinology (Baltimore, Md.), 1993, Volume: 7, Issue:9

    Topics: Animals; Base Sequence; Blotting, Northern; Cell Line; Cell Nucleus; Cycloheximide; Dactinomycin; De

1993